0.2925
price down icon3.53%   -0.0107
after-market 시간 외 거래: .29 -0.0025 -0.85%
loading
전일 마감가:
$0.3032
열려 있는:
$0.308
하루 거래량:
3.50M
Relative Volume:
1.28
시가총액:
$3.47M
수익:
-
순이익/손실:
$-11.53M
주가수익비율:
-0.0607
EPS:
-4.82
순현금흐름:
$-11.12M
1주 성능:
+22.03%
1개월 성능:
+27.51%
6개월 성능:
-74.69%
1년 성능:
-81.49%
1일 변동 폭
Value
$0.29
$0.3227
1주일 범위
Value
$0.24
$0.3448
52주 변동 폭
Value
$0.15
$3.10

프로세사 파마슈티컬스 Stock (PCSA) Company Profile

Name
명칭
Processa Pharmaceuticals Inc
Name
전화
443-776-3133
Name
주소
7380 COCA COLA DRIVE, HANOVER
Name
직원
13
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
PCSA's Discussions on Twitter

PCSA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.2925 2.85M 0 -11.53M -11.12M -4.82
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-04-25 개시 H.C. Wainwright Buy

프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스

pulisher
May 30, 2025

Processa Pharmaceuticals (PCSA) Highlights Cancer Drug Advances at ASCO 2025 | PCSA Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals presents cancer drug advances at ASCO - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals Highlights Next Generation Cancer Therapies with Three Accepted Abstracts at 2025 ASCO Annual Meeting - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Latest Clinical Trial Data: Processa Presents 3 Cancer Treatment Breakthroughs at ASCO 2025 - Stock Titan

May 30, 2025
pulisher
May 24, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Stock Price Down 1.5% – What’s Next? - Defense World

May 24, 2025
pulisher
May 09, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price - MSN

May 09, 2025
pulisher
May 08, 2025

Processa Pharmaceuticals Announces Launch of Website (www.Necrobiosislipoidicastudy.com) to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499 - Barchart.com

May 08, 2025
pulisher
May 02, 2025

There is no way Processa Pharmaceuticals Inc (PCSA) can keep these numbers up - Sete News

May 02, 2025
pulisher
May 02, 2025

Processa Pharmaceuticals (PCSA) Expected to Announce Earnings on Friday - Defense World

May 02, 2025
pulisher
May 01, 2025

Processa Pharmaceuticals Inc: Rising -91.68% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

May 01, 2025
pulisher
Apr 30, 2025

Taking a Closer Look At Processa Pharmaceuticals Inc (PCSA) Following Its Recent Trade - knoxdaily.com

Apr 30, 2025
pulisher
Apr 24, 2025

Processa Pharmaceuticals Inc [PCSA] Shares Rise 8.43 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN

Apr 24, 2025
pulisher
Apr 22, 2025

Processa Pharmaceuticals Inc (PCSA) can make a big difference with a little luck - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

A Closer Look at Processa Pharmaceuticals Inc (PCSA) Stock Gains - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Recent Insider Activity Suggests Potential Gains for Processa Pharmaceuticals Inc (PCSA) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 15, 2025

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Project Optimus: Processa Unveils New Approach for Rare Disease Treatment Success - Stock Titan

Apr 15, 2025
pulisher
Apr 12, 2025

Data-Based Insights About Processa Pharmaceuticals Inc (PCSA) - stocksregister.com

Apr 12, 2025
pulisher
Apr 11, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.22 - Investing.com

Apr 11, 2025
pulisher
Apr 10, 2025

PCSA Stock Sees Decline of Approximately -11.67% in Last Five Days - knoxdaily.com

Apr 10, 2025
pulisher
Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com India

Apr 02, 2025
pulisher
Mar 28, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com

Mar 25, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals Inc. (PCSA) reports earnings - qz.com

Mar 20, 2025
pulisher
Mar 18, 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India

Mar 13, 2025
pulisher
Mar 11, 2025

Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart

Mar 11, 2025
pulisher
Mar 04, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com

Mar 04, 2025
pulisher
Feb 28, 2025

Processa Pharma Stock Price, Quotes and Forecasts - Benzinga

Feb 28, 2025
pulisher
Feb 21, 2025

The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl

Feb 21, 2025
pulisher
Feb 21, 2025

Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions

Feb 21, 2025
pulisher
Feb 21, 2025

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025
pulisher
Feb 20, 2025

10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 20, 2025
pulisher
Feb 13, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria

Feb 13, 2025
pulisher
Feb 11, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater

Feb 10, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025
pulisher
Feb 03, 2025

Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex

Feb 03, 2025

프로세사 파마슈티컬스 (PCSA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):